{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:21:37Z","timestamp":1791778897119,"version":"4.3.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,2,19]],"date-time":"2004-02-19T00:00:00Z","timestamp":1077148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,2,19]],"date-time":"2004-02-19T00:00:00Z","timestamp":1077148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2004,4,1]]},"DOI":"10.1038\/sj.leu.2403313","type":"journal-article","created":{"date-parts":[[2004,2,19]],"date-time":"2004-02-19T11:10:40Z","timestamp":1077189040000},"page":"734-742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":148,"title":["Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias"],"prefix":"10.1038","volume":"18","author":[{"given":"P","family":"Vandenberghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Wlodarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Michaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Zach\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Boogaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Vanstraelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-C","family":"Herregods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Van Hoof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Selleslag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Roufosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Maerevoet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Cools","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D G","family":"Gilliland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hagemeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Marynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,2,19]]},"reference":[{"key":"BF2403313_CR1","first-page":"2","volume":"95","author":"BJ Bain","year":"1996","unstructured":"Bain BJ . Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome. Br J Haematol 1996; 95: 2\u20139.","journal-title":"Br J Haematol"},{"key":"BF2403313_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00062752-200001000-00005","volume":"7","author":"BJ Bain","year":"2000","unstructured":"Bain BJ . Hypereosinophilia. Curr Opin Hematol 2000; 7: 21\u201325.","journal-title":"Curr Opin Hematol"},{"key":"BF2403313_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-197501000-00001","volume":"54","author":"MJ Chusid","year":"1975","unstructured":"Chusid MJ, Dale DC, West BC, Wolff SM . The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975; 54: 1\u201327.","journal-title":"Medicine (Baltimore)"},{"key":"BF2403313_CR4","first-page":"29","volume-title":"WHO Classification of Tumours: Pathology and Genetics. Tumors of Haematopoietic and Lymphoid tissues","author":"B Bain","year":"2001","unstructured":"Bain B, Pierre R, Imbert M, Vardiman JW, Brunning RD, Flandrin G . Chronic eosinophilic leukemia and the hypereosinophilic syndrome. In: Jaffe ES, Harris NL, Vardiman JW (eds) WHO Classification of Tumours: Pathology and Genetics. Tumors of Haematopoietic and Lymphoid tissues. Lyon: IARC Press, 2001, pp 29\u201331."},{"key":"BF2403313_CR5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1182\/blood.V63.4.779.779","volume":"63","author":"J Zittoun","year":"1984","unstructured":"Zittoun J, Farcet JP, Marquet J, Sultan C, Zittoun R . Cobalamin (vitamin B12) and B12 binding proteins in hypereosinophilic syndromes and secondary eosinophilia. Blood 1984; 63: 779\u2013783.","journal-title":"Blood"},{"key":"BF2403313_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.7326\/0003-4819-97-1-78","volume":"97","author":"AS Fauci","year":"1982","unstructured":"Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH . NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982; 97: 78\u201392.","journal-title":"Ann Intern Med"},{"key":"BF2403313_CR7","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","volume":"83","author":"P Weller","year":"1994","unstructured":"Weller P, Bubley G . The idiopathic hypereosinophilic syndrome. Blood 1994; 83: 2759\u20132779.","journal-title":"Blood"},{"key":"BF2403313_CR8","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa025217","volume":"348","author":"J Cools","year":"2003","unstructured":"Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003; 348: 1201\u20131214.","journal-title":"N Engl J Med"},{"key":"BF2403313_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1535-6108(03)00108-9","volume":"5","author":"J Cools","year":"2003","unstructured":"Cools J, Stover EH, Boulton CL, Gotlib J, Legare RD, Amaral SM et al. PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRalpha-induced myeloproliferative disease. PG-459-69. Cancer Cell 2003; 5: 459\u2013469.","journal-title":"Cancer Cell"},{"key":"BF2403313_CR10","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(02)08505-7","volume":"359","author":"GJ Gleich","year":"2002","unstructured":"Gleich GJ, Leiferman KM, Pardanani A, Tefferi A, Butterfield JH . Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet 2002; 359: 1577\u20131578.","journal-title":"Lancet"},{"key":"BF2403313_CR11","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1182\/blood-2002-10-3103","volume":"101","author":"A Pardanani","year":"2003","unstructured":"Pardanani A, Reeder T, Porrata LF, Li C-Y, Tazelaar HD, Baxter EJ et al. Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood 2003; 101: 3391\u20133397.","journal-title":"Blood"},{"key":"BF2403313_CR12","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1182\/blood-2003-01-0081","volume":"101","author":"J Cortes","year":"2003","unstructured":"Cortes J, Ault P, Koller C, Thomas D, Ferrajoli A, Wierda W et al. Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. Blood 2003; 101: 4714\u20134716.","journal-title":"Blood"},{"key":"BF2403313_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1046\/j.1365-2141.1996.00298.x","volume":"92","author":"ML Malbrain","year":"1996","unstructured":"Malbrain ML, Van den Bergh H, Zachee P . Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome: complete haematological and cytogenetic remission induced by interferon-alpha in a case with a unique chromosomal abnormality. Br J Haematol 1996; 92: 176\u2013183.","journal-title":"Br J Haematol"},{"key":"BF2403313_CR14","volume-title":"An International System for Human Cytogenetic Nomenclature","author":"F Mitelman","year":"1995","unstructured":"Mitelman F, ISCN. An International System for Human Cytogenetic Nomenclature. Basel: S Karger, 1995."},{"key":"BF2403313_CR15","doi-asserted-by":"crossref","unstructured":"Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3, RESEARCH0034.1-0034.11.","DOI":"10.1186\/gb-2002-3-7-research0034"},{"key":"BF2403313_CR16","doi-asserted-by":"crossref","unstructured":"Cools J, Quentmeier H, Huntly BJ, Marynen P, Griffin JD, Drexler HG et al. The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA positive chronic eosinophilic leukemia. Blood 2003, Nov 20 [Epub ahead of print], in press.","DOI":"10.1182\/blood-2003-07-2479"},{"key":"BF2403313_CR17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ijc.10169","volume":"98","author":"JI Martin-Subero","year":"2002","unstructured":"Martin-Subero JI, Harder L, Gesk S, Schlegelberger B, Grote W, Martinez-Climent JA et al. Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci. Int J Cancer 2002; 98: 470\u2013474.","journal-title":"Int J Cancer"},{"key":"BF2403313_CR18","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1182\/blood-2003-05-1627","volume":"102","author":"A Pardanani","year":"2003","unstructured":"Pardanani A, Ketterling RP, Brockman SR, Flynn HC, Paternoster SF, Shearer BM et al. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood 2003; 102: 3093\u20133096.","journal-title":"Blood"},{"key":"BF2403313_CR19","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","volume":"101","author":"AD Klion","year":"2003","unstructured":"Klion AD, Noel P, Akin C, Law MA, Gilliland DG, Cools J et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 2003; 101: 4660\u20134666.","journal-title":"Blood"},{"key":"BF2403313_CR20","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1056\/NEJM200306263482616","volume":"348","author":"FE Roufosse","year":"2003","unstructured":"Roufosse FE, Goldman M, Cogan E . Hypereosinophilic syndrome. N Engl J Med 2003; 348: 2687.","journal-title":"N Engl J Med"},{"key":"BF2403313_CR21","first-page":"292","volume-title":"WHO Classification of Tumours: Pathology and Genetics. Tumors of Haematopoietic and Lymphoid tissues","author":"P Valent","year":"2001","unstructured":"Valent P, Horny HP, Li CY, Longley BJ, Metcalfe DD, Parwaresch RM et al. Mastocytosis. In: Jaffe ES, Harris NL, Vardiman JW (eds) WHO Classification of Tumours: Pathology and Genetics. Tumors of Haematopoietic and Lymphoid tissues. Lyon: IARC Press, 2001, pp 292\u2013302."}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403313.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403313","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403313.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:51:31Z","timestamp":1648777891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,19]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4,1]]}},"alternative-id":["BF2403313"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403313","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,19]]},"assertion":[{"value":"22 October 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}